Cargando…

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis

Detalles Bibliográficos
Autores principales: Shin, Sungsik, Chung, Kee Yang, Kim, Dae Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884726/
https://www.ncbi.nlm.nih.gov/pubmed/27274648
http://dx.doi.org/10.5021/ad.2016.28.3.402
_version_ 1782434405398085632
author Shin, Sungsik
Chung, Kee Yang
Kim, Dae Suk
author_facet Shin, Sungsik
Chung, Kee Yang
Kim, Dae Suk
author_sort Shin, Sungsik
collection PubMed
description
format Online
Article
Text
id pubmed-4884726
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-48847262016-06-03 Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis Shin, Sungsik Chung, Kee Yang Kim, Dae Suk Ann Dermatol Letter to the Editor Korean Dermatological Association; The Korean Society for Investigative Dermatology 2016-06 2016-05-25 /pmc/articles/PMC4884726/ /pubmed/27274648 http://dx.doi.org/10.5021/ad.2016.28.3.402 Text en Copyright © 2016 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Shin, Sungsik
Chung, Kee Yang
Kim, Dae Suk
Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
title Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
title_full Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
title_fullStr Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
title_full_unstemmed Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
title_short Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis
title_sort development of rheumatoid nodules after anti-tumor necrosis factor-α treatment with adalimumab for rheumatoid arthritis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884726/
https://www.ncbi.nlm.nih.gov/pubmed/27274648
http://dx.doi.org/10.5021/ad.2016.28.3.402
work_keys_str_mv AT shinsungsik developmentofrheumatoidnodulesafterantitumornecrosisfactoratreatmentwithadalimumabforrheumatoidarthritis
AT chungkeeyang developmentofrheumatoidnodulesafterantitumornecrosisfactoratreatmentwithadalimumabforrheumatoidarthritis
AT kimdaesuk developmentofrheumatoidnodulesafterantitumornecrosisfactoratreatmentwithadalimumabforrheumatoidarthritis